Sandu Pharmaceuticals Reports 33.8% Jump in Q1 Net Profit Despite Revenue Decline Aug 15, 2025
Sandu Pharmaceuticals Reports Q1 Profit, Declares Dividend, and Schedules 40th AGM Aug 13, 2025
More news about Sandu Pharmaceuticals
16Jun 25
Sun Pharma's Halol Facility Faces FDA Scrutiny; Leadership Transition Announced
Sun Pharmaceuticals received eight FDA observations for its Halol facility, which is already under import alert. The company also announced a leadership transition, with Kirti Ganorkar set to become Managing Director on September 1, 2025, succeeding founder Dilip Shanghvi.